Financial Statements · From SEC 10-K & 10-Q XBRL Filings
CME Group Inc. Revenue & Financial Statements
CME Group Inc. reported revenue of $6.5B for the fiscal year ended December 31, 2025, up 6.4% year over year, with net income of $4.1B and diluted EPS of $11.16.
- Company
- CME Group Inc. CME · NASDAQ
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 4.7B | 5.0B | 5.6B | 6.1B | 6.5B |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | 2.6B | 3.0B | 3.4B | 3.9B | 4.2B |
| Pretax income | 645.1M | 198.6M | 253.1M | 235.5M | 522.9M |
| Net income | 2.6B | 2.5B | 3.3B | 3.5B | 4.1B |
| Diluted EPS | 7.29 | 7.40 | 8.86 | 9.67 | 11.16 |
| EBITDA | 2.8B | 3.2B | 3.6B | 4.0B | 4.3B |
Quarterly
| USD | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.5B | 1.6B | 1.5B | 1.6B | 1.7B | 1.5B | 1.6B | 1.9B |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | 1.0B | 1.0B | 947.1M | 1.1B | 1.1B | 972.6M | 1.0B | 1.3B |
| Pretax income | 1.2B | 1.2B | 1.1B | 1.2B | 1.3B | 1.2B | 1.6B | 1.5B |
| Net income | 883.2M | 912.8M | 874.6M | 956.2M | 1.0B | 908.0M | 1.2B | 1.2B |
| Diluted EPS | 2.42 | 2.50 | 2.40 | 2.62 | 2.81 | 2.49 | 3.24 | 3.18 |
| EBITDA | 1.0B | 1.1B | — | 1.1B | 1.2B | 999.0M | — | 1.3B |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 196.8B | 174.2B | 129.7B | 137.4B | 198.4B |
| Current assets | 161.8B | 139.1B | 94.9B | 103.0B | 165.4B |
| Cash & equivalents | 2.8B | 2.7B | 2.9B | 2.9B | 4.4B |
| Total liabilities | 169.4B | 147.3B | 103.0B | 111.0B | 169.7B |
| Current liabilities | 160.4B | 137.7B | 93.4B | 102.3B | 160.3B |
| Long-term debt | — | — | — | — | — |
| Total debt | 749.4M | 16.0M | 0 | 749.8M | 0 |
| Stockholders’ equity | 27.4B | 26.9B | 26.7B | 26.5B | 28.7B |
| Net debt | (2.1B) | (2.7B) | (2.9B) | (2.1B) | (4.4B) |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 2.4B | 3.1B | 3.5B | 3.7B | 4.3B |
| Investing cash flow | 58.4M | (489.8M) | 20.9M | (82.6M) | 1.5B |
| Financing cash flow | 69.9B | (25.4B) | (48.3B) | 5.1B | 56.5B |
| Capital expenditure | 127.2M | 89.7M | 76.4M | 94.0M | 83.5M |
| Free cash flow | 2.3B | 3.0B | 3.4B | 3.6B | 4.2B |
| Dividends paid | 2.2B | 2.6B | 3.2B | 3.6B | 3.9B |
| Stock-based compensation | 75.2M | 84.3M | 82.9M | 89.5M | 94.8M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every CME filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.